Press Releases

Application for Listing on NASDAQ Capital Market

Lexington, Massachusetts, United States and Sydney, Australia – 28 October 2014 – GI Dynamics, Inc. (ASX: GID) (“GI Dynamics” or the “Company”), a medical device company developing innovative treatments for type 2 diabetes and obesity, announced today that it has filed an application to list its...

read more

GI Dynamics Suspends Shipments of CE Marked Product

Company Provides Preliminary Update on Third Quarter Revenues LEXINGTON, Massachusetts – 6 October 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that its Notified Body in the European Union, an...

read more

New Clinical Data Highlighting Safety and Efficacy of EndoBarrier® Therapy Presented at the 19th World Congress of International Federation for the Surgery of Obesity and Metabolic Disorders

Data Further Demonstrate the Utility of EndoBarrier Therapy in the Treatment of Patients with Type 2 Diabetes and Obesity MONTREAL, Canada, LEXINGTON, United States and SYDNEY, Australia – 29 August 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for...

read more

Appendix 4C Quarterly Report Quarter ended 30 June 2014

GI Dynamics to Hold Briefing Call and Webcast on Financial Results for Second Quarter 2014 on Monday, 4 August 2014 at 6 p.m. U.S. EDT  / Tuesday, 5 August 2014 at 8 a.m. AEST     LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 31 July 2014 – GI Dynamics, Inc. (ASX: GID) (GI...

read more
Page 7 of 18« First...56789...Last »